ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,755.83
0.04%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. BriaCell Therapeutics Corporation (BCTXW) Share Price

BCTXW BriaCell Therapeutics Corporation

0.52
0.0203 (4.06%)
01 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 BriaCell Therapeutics Corporation NASDAQ:BCTXW NASDAQ Equity Warrant  Warrant
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.0203 4.06 0.52 0.35 0.895 0.535899 0.35 0.4674 330,486 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Aircraft  -20.3M -1.2703 -8.34 169.41M
 Type  Size  Price  Time  Units 
 13 100 0.47 20:00:00 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore BCTXW News
30/05/202413:00GLOBEBriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast Cancer
28/05/202413:00GLOBEBriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
24/05/202413:58EDGAR2Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
24/05/202413:00GLOBEBriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
20/05/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
17/05/202421:51EDGAR2Form 8-K - Current report
17/05/202421:33GLOBEBriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
Period
Draw mode
Data Downloads for BCTXW

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest BriaCell Therapeutics Corporation Articles